Updates matching "National"

More than 100 organizations representing millions of patients, providers and consumers joined together in letters and formal comments to Congressional leadership and federal agencies urging the withdrawal of a proposed rule on short-term, limited duration insurance plans (STLD).

oday the American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Department of Health and Human Services (HHS) on proposed changes to rules governing short-term, limited duration insurance plans (STLD). The comments detail how the proposed rule could divide the individual insurance market and significantly weaken patient protections, leaving cancer patients and survivors with few meaningful or affordable coverage choices.

WASHINGTON, D.C. – Six leading public health and medical organizations today urged the U.S. Food and Drug Administration to take strong and immediate action to address the dramatic rise in teen use of Juul electronic cigarettes, which has been widely reported by media and educators across the United States. The

The American Cancer Society Cancer Action Network (ACS CAN) today released a report examining the most common patient barriers to cancer clinical trial enrollment. Made public at ACS CAN’s annual national policy forum, the report found only about one in four (27%) patients has access to clinical trials where they are being treated. Yet, if asked to enroll in an available trial, more than half of eligible patients typically agree to do so.

WASHINGTON, D.C. – Today the Senate Health, Education, Labor and Pensions Committee (HELP) held a hearing on the Opioid Crisis Response Act of 2018. Included in the proposal are several promising provisions that aim to address addiction while maintaining access to necessary relief for individuals fighting pain from cancer and

A report released today by the Centers for Disease Control and Prevention’s (CDC) Office on Smoking and Health (OSH) provided an updated snapshot of states’ Medicaid coverage for tobacco cessation.

The Centers for Medicare and Medicaid Services (CMS) released a final Medicare rule yesterday that did not include a proposal that would have set hard limits on opioid pain medication at the pharmacy unless an insurer authorized special permission for a larger dose.